Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies

Letter Oncology

Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient

Joshua A. Hill et al.

CANCER CELL (2021)

Add to Collection

Letter Oncology

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies

Lee M. Greenberger et al.

CANCER CELL (2021)

Add to Collection

Editorial Material Oncology

Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution

Elizabeth A. Griffiths et al.

Summary: SARS-CoV-2 vaccines are effective in preventing severe COVID-19, especially for cancer patients. Studies in Cancer Cell reveal the heterogeneity of immune responses to vaccination among cancer patients, highlighting the need for further research in this area.

CANCER CELL (2021)

Add to Collection

Article Virology

Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay

Katarina Resman Rus et al.

Summary: The study compared Elecsys Anti-SARS-CoV-2 S (Elecsys-S) with neutralization tests (NT) for detecting and quantifying anti-SARS-CoV-2 neutralizing antibodies (NAb). Elecsys-S showed a high detection rate of pan-anti-S1-RBD-SARS-CoV-2 antibodies and moderate agreement with NT results.

JOURNAL OF CLINICAL VIROLOGY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

SARS-CoV-2 Variants in Patients with Immunosuppression

Lawrence Corey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Oncology

COVID-19 and Cancer: Current Challenges and Perspectives

Ziad Bakouny et al.

CANCER CELL (2020)

Add to Collection

Review Hematology

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

Abi Vijenthira et al.

BLOOD (2020)

Add to Collection

Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies

Related references

Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies

Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution

Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay

SARS-CoV-2 Variants in Patients with Immunosuppression

COVID-19 and Cancer: Current Challenges and Perspectives

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

Export Citation

Share Paper